Taken together, these findings indicate that RBP, after penetrating cancer cells, inhibited RAS–RAF-mediated ERK/MAPK signaling and suppressed the migration, proliferation, and growth of MDA-MB-231 cells (Fig. 6). Here, RAF1 is linked to cancer.